Vinpocetine

Category
alkaloid
Routes
Oral (PO)
Half-Life (t½)
PO: 4.83h
Formula
C22H26N2O2
Molecular Weight
350.45 g/mol
PubChem CID
443955
Aliases
Cavinton, Ethyl apovincaminate

Pharmacological Mechanism

Cerebral vasodilator — selective PDE1 inhibitor → increased cGMP in cerebral vasculature → vasodilation without systemic hypotension. Also inhibits voltage-dependent Na⁺ channels (mild neuroprotective) and raises cerebral glucose uptake. Eastern European cerebrovascular Rx since 1978.

Half-Life & Elimination Curve (PO: 4.83h)

100%50%25%12.5%0%0h0×t½4.83h1×t½9.66h2×t½14.5h3×t½19.3h4×t½24.1h5×t½0×t½ (0h): 100% remaining (~7.79 µg/L)1×t½ (4.83h): 50% remaining (~3.9 µg/L)2×t½ (9.66h): 25% remaining (~1.95 µg/L)3×t½ (14.5h): 12.5% remaining (~0.974 µg/L)4×t½ (19.3h): 6.3% remaining (~0.487 µg/L)5×t½ (24.1h): 3.1% remaining (~0.243 µg/L)
Plasma (PO)t½ Decay (4.83h)
  • 0×t½0h100% (7.79 µg/L)
  • 1×t½4.83h50% (3.9 µg/L)
  • 2×t½9.66h25% (1.95 µg/L)
  • 3×t½14.5h12.5% (0.974 µg/L)
  • 4×t½19.3h6.3% (0.487 µg/L)
  • 5×t½24.1h3.1% (0.243 µg/L)
Elimination t½4.83h (PO)
Rate Constant (ke)0.144 h⁻¹
Time to Peak (Tmax)2.27h
Est. Peak (Cmax)7.79 µg/L
Clearance (CL)50.2 L/h
97% Washout (5×t½)24.1h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References